Longevity Tech Venture 'Regenesome' Exhibits at 'GATEWAY Tech TAKANAWA 2026', Showcasing Development of Nanoparticles That Reach the Brain
NQ Score
0/100
N1 Content Completeness
8
Key facts
- Longevity Tech Venture 'Regenesome' Exhibits at 'GATEWAY Tech TAKANAWA 2026', Showcasing Development of Nanoparticles That Reach the Brain
- Regenesome Co., Ltd. exhibited at 'GATEWAY Tech TAKANAWA 2026', presenting its research on longevity using hypoxic environments and the development of nanoparticles capable of delivering drugs to the brain.
- Source: PR TIMES
- Date: Thu Jun 04 2026 16:00:02 GMT+0900 (Japan Standard Time)
Direct answer
Regenesome Co., Ltd. exhibited at 'GATEWAY Tech TAKANAWA 2026', presenting its research on longevity using hypoxic environments and the development of nanoparticles capable of delivering drugs to the brain.
- Citation
- Longevity Tech Venture 'Regenesome' Exhibits at 'GATEWAY Tech TAKANAWA 2026', Showcasing Development of Nanoparticles That Reach the Brain (Thu Jun 04 2026 16:00:02 GMT+0900 (Japan Standard Time)), PR TIMES
- Source
- PR TIMES
- Date
- Thu Jun 04 2026 16:00:02 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
Regenesome Co., Ltd. exhibited at 'GATEWAY Tech TAKANAWA 2026', presenting its research on longevity using hypoxic environments and the development of nanoparticles capable of delivering drugs to the brain.
AI Analysis
Frequently Asked Questions
- Q: What is Regenesome's 'disc-shaped' nanoparticle?
- A: It is a uniquely shaped nanoparticle under development to overcome the blood-brain barrier, in collaboration with the Institute of Science Tokyo.
- Q: What is the 'Longevity Room'?
- A: It is a health program that creates a hypoxic environment to activate mitochondria, similar to the principle of high-altitude training.
- Q: Who is Regenesome's parent company?
- A: Space Seed Holdings Co., Ltd., a space-focused deep-tech venture builder.